It’s the end of an era—for pharma TV advertising, anyway. Humira’s reign at the top of the TV ad spenders is over. AbbVie had been ratcheting back the brand’s TV budget over the past few months, but, ...
AbbVie’s blockbuster giant, Humira, is used to being top dog in the pharma industry. But it had a rude awakening in 2021, when it’s massive $20 billion annual sales figure was shattered by Pfizer’s ...
Image above from a recent Humira ad. The Humira wars have begun, as the first branded biosimilar to break Abbvie’s 20-year exclusivity on the top-selling anti-inflammatory drug has launched, cutting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results